TrialEuropean journal of clinical pharmacology2008

CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction.

Ksenia Goryachkina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.